Merck expands CRISPR patent portfolio
12-05-2020
Merck KGaA secures second US CRISPR patent
09-04-2020
UK firm successfully challenges ‘Vagisan’ TM in Singapore
28-02-2020
panuwach / Shutterstock.com
The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Merck KGaA, CRISPR, MilliporeSigma, patent, gene-editing, genetics, Udit Batra, genome
